NCT04790565View on ClinicalTrials.gov

Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

October 1, 2022

Conditions
Carbapenem-Resistant Enterobacteriaceae Infection
Interventions
BIOLOGICAL

FMT

Fecal microbiota in frozen capsules

Trial Locations (1)

Unknown

Rambam Health Care Campus, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT04790565 - Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae | Biotech Hunter | Biotech Hunter